Xi'an International Medical Investment Company Limited (SHE:000516)
China · Delayed Price · Currency is CNY 4.280
+0.020 (0.47%)
Aug 3, 2026, 3:05 PM CST
SHE:000516 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 9,538 | 9,605 | 11,895 | 18,275 | 27,755 | 25,019 | |
Market Cap Growth | -22.97% | -19.25% | -34.91% | -34.16% | 10.94% | 3.23% |
Enterprise Value | 13,100 | 13,370 | 15,727 | 22,012 | 32,021 | 27,828 |
Last Close Price | 4.26 | 4.29 | 5.28 | 8.11 | 12.24 | 11.03 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Forward PE | - | 64.75 | 81.23 | 137.93 | 74.61 | 299.20 |
PS Ratio | 2.36 | 2.36 | 2.47 | 3.96 | 10.24 | 8.57 |
PB Ratio | 3.25 | 3.19 | 3.43 | 4.79 | 6.53 | 4.69 |
P/TBV Ratio | 3.68 | 3.64 | 4.01 | 5.78 | 7.99 | 5.40 |
P/FCF Ratio | 8.47 | 9.47 | 25.78 | 56.29 | - | - |
P/OCF Ratio | 7.44 | 7.53 | 11.79 | 16.81 | 60.16 | 54.83 |
PEG Ratio | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.24 | 3.28 | 3.27 | 4.77 | 11.81 | 9.53 |
EV/EBITDA Ratio | 30.96 | 35.55 | 29.43 | 49.24 | - | - |
EV/FCF Ratio | 11.64 | 13.19 | 34.09 | 67.80 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.46 | 1.43 | 1.34 | 1.23 | 1.05 | 0.96 |
Debt / EBITDA Ratio | 10.13 | 11.40 | 8.68 | 10.46 | - | - |
Debt / FCF Ratio | 3.81 | 4.23 | 10.05 | 14.40 | - | - |
Net Debt / Equity Ratio | 1.33 | 1.29 | 1.14 | 0.94 | 0.74 | 0.62 |
Net Debt / EBITDA Ratio | 9.21 | 10.27 | 7.40 | 8.04 | -11.38 | -31.20 |
Net Debt / FCF Ratio | 3.46 | 3.81 | 8.58 | 11.07 | -4.31 | -2.73 |
Asset Turnover | 0.41 | 0.40 | 0.44 | 0.38 | 0.20 | 0.23 |
Inventory Turnover | 60.43 | 50.69 | 55.09 | 56.92 | 37.99 | 40.85 |
Quick Ratio | 0.22 | 0.23 | 0.35 | 0.43 | 0.32 | 0.63 |
Current Ratio | 0.25 | 0.25 | 0.39 | 0.47 | 0.67 | 0.67 |
Return on Equity (ROE) | -11.53% | -13.00% | -10.02% | -11.70% | -24.95% | -16.31% |
Return on Assets (ROA) | -1.48% | -1.82% | -1.12% | -1.64% | -4.21% | -3.31% |
Return on Invested Capital (ROIC) | -3.42% | -4.14% | -2.64% | -4.37% | -11.19% | -8.06% |
Return on Capital Employed (ROCE) | -4.40% | -5.60% | -3.00% | -4.50% | -11.60% | -6.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.67% | -3.26% | -2.14% | -2.02% | -4.24% | -3.29% |
FCF Yield | 11.80% | 10.56% | 3.88% | 1.78% | -2.62% | -4.81% |
Buyback Yield / Dilution | 3.39% | 3.20% | -0.35% | -1.74% | -1.84% | 2.03% |
Total Shareholder Return | 3.39% | 3.20% | -0.35% | -1.74% | -1.84% | 2.03% |